The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.
about
The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.
description
clinical trial
@en
klinisch onderzoek
@nl
name
The Use of FES-PET Imaging as ...... tuzumab + Pertuzumab + Taxane.
@en
type
label
The Use of FES-PET Imaging as ...... tuzumab + Pertuzumab + Taxane.
@en
prefLabel
The Use of FES-PET Imaging as ...... tuzumab + Pertuzumab + Taxane.
@en
P4844
P1476
The Use of FES-PET Imaging as ...... tuzumab + Pertuzumab + Taxane.
@en
P17
P1813
REVER
@en
P3098
NCT03619044
P580
2018-09-01T00:00:00Z
P582
2020-11-01T00:00:00Z